AMAG Pharmaceuticals Rises 8.8% On Upgrade News (AMAG)

Shares of AMAG Pharmaceuticals, Inc. AMAG are currently up 8.8% at $18.16 per share during Tuesday afternoon trading. The company's share price got a boost when Madison Williams raised it rating for the stock from Accumulate to Buy. Today's trading range for shares of AMAG Pharmaceuticals, Inc has been between $17.22 and $18.30 per share. The consensus price target of analysts covering the company's stock is $22.17 per share. Volume of 645,000 shares is above the daily average volume of 535,000 shares. AMAG Pharmaceuticals, Inc. (AMAG) is a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The company manufactures and sells Feraheme (ferumoxytol) Injection for intravenous use. Read more from Benzinga's Company news.